Recombinant Macaca mulatta (Rhesus macaque) Interleukin-1 receptor accessory protein (IL1RAP)

Shipped with Ice Packs
In Stock

Description

Basic Properties

The recombinant Rhesus monkey IL1RAP is a well-characterized protein with defined molecular properties. When expressed in human embryonic kidney (HEK293) cells with a His-tag at the C-terminus, the protein spans from Met1 to Glu359, comprising 350 amino acids with a calculated molecular mass of 40.56 kDa . The protein shares significant homology with human IL1RAP, making it valuable for comparative studies of interleukin signaling across primate species.

Protein Architecture

IL1RAP belongs to the interleukin-1 receptor family and features characteristic structural domains:

  • An extracellular domain containing immunoglobulin-like regions responsible for ligand interaction

  • A transmembrane domain anchoring the protein to the cell membrane

  • An intracellular Toll/IL-1R (TIR) domain essential for signal transduction

The protein exists in multiple isoforms resulting from alternative splicing, with both membrane-bound and soluble variants that differ in their C-terminal regions . The ratio of soluble to membrane-bound forms increases notably during acute-phase responses or stress conditions, suggesting a regulatory mechanism for IL-1 signaling .

Production and Purification

Recombinant Rhesus monkey IL1RAP is typically produced in mammalian expression systems to ensure proper folding and post-translational modifications. The protein is commonly expressed with His-tags or other fusion partners to facilitate purification. The production specifications for commercially available recombinant IL1RAP include:

ParameterSpecification
Expression SystemHEK293 cells
Fusion TagHis (C-terminal)
Protein LengthMet1-Glu359
Molecular Mass40.56 kDa
FormLyophilized from sterile PBS, pH 7.4
Purity>90% as determined by SDS-PAGE
Endotoxin Level<1.0 EU per μg protein

Table 1: Properties of Recombinant Rhesus monkey IL1RAP protein

Role in IL-1 Signaling

IL1RAP serves as a critical co-receptor in the IL-1 signaling pathway. It does not bind to interleukin-1 directly but associates with IL1R1 that has bound IL1B to form a high-affinity receptor complex . This complex formation is necessary for efficient signal transduction and subsequent activation of downstream pathways including NF-kappa-B activation . The signaling cascade involves:

  1. Initial binding of IL-1 to IL-1R1

  2. Recruitment of IL1RAP to form a heterotrimeric complex

  3. Conformational changes in the cytoplasmic TIR domains

  4. Recruitment of adapter molecules including TOLLIP, MYD88, and IRAK1/2

  5. Activation of downstream kinases and transcription factors

  6. Induction of pro-inflammatory gene expression

The protein exhibits remarkable specificity in its co-receptor functions, showing strong interactions with multiple interleukin receptor family members as evidenced by high STRING interaction scores .

Extended Signaling Functions

Beyond the canonical IL-1 pathway, IL1RAP also functions as a co-receptor for IL1RL2 in the IL-36 signaling system . This versatility points to IL1RAP's broader role in coordinating various inflammatory signals. The protein's function extends to multiple signaling networks that collectively regulate inflammation, immune cell activation, and tissue homeostasis.

Protein-Protein Interactions

STRING database analysis reveals the extensive protein interaction network of Macaca mulatta IL1RAP, highlighting its central role in inflammatory signaling cascades. The protein shows particularly strong interactions with multiple components of the interleukin signaling system:

Interaction PartnerDescriptionInteraction Score
IL1BInterleukin-1 beta0.981
IL33Interleukin-330.977
IL1R1Interleukin 1 receptor type 10.967
IL1RL1Interleukin 1 receptor like 10.960
IL1R2Interleukin 1 receptor type 20.941
IL1RL2Interleukin 1 receptor like 20.930
PTPRDProtein tyrosine phosphatase receptor type D0.922
PTPRSProtein tyrosine phosphatase receptor type S0.858
IL1AInterleukin-1 alpha0.841
MYD88Myeloid differentiation primary response protein0.791

Table 2: Functional interaction partners of IL1RAP with confidence scores

The remarkably high interaction scores with IL1B, IL33, and IL1R1 (all above 0.96) underscore IL1RAP's central role in mediating signals from multiple interleukin family members. The interaction with MYD88 further confirms its involvement in the canonical signaling pathway leading to NF-kappa-B activation.

Role in Immune Regulation

IL1RAP plays a significant role in immune regulation by facilitating IL-1 signaling, which is crucial for initiating and maintaining inflammatory responses . This signaling pathway is essential for:

  • Activation of innate immune responses

  • Production of pro-inflammatory cytokines

  • Recruitment and activation of immune cells

  • Amplification of inflammatory cascades

  • Regulation of adaptive immune responses

The balance between membrane-bound and soluble IL1RAP forms contributes to the fine-tuning of these immune responses, with soluble forms potentially acting as decoy receptors to dampen excessive inflammation .

Comparative Studies with Human IL1RAP

The high degree of conservation between rhesus and human IL1RAP makes the recombinant Macaca mulatta protein valuable for comparative studies. Researchers can investigate species-specific differences in IL-1 signaling pathways and test the cross-reactivity of therapeutic agents targeting IL1RAP before advancing to human studies. This approach is particularly relevant given the established use of rhesus macaques as models for human inflammatory and autoimmune conditions.

Applications in Drug Discovery

Recombinant Macaca mulatta IL1RAP has significant applications in drug discovery pipelines, particularly for the development of therapeutics targeting the IL-1 signaling pathway. These applications include:

  • High-throughput screening of small molecule inhibitors

  • Development and testing of therapeutic antibodies

  • Structure-based drug design targeting the IL-1 receptor complex

  • Validation studies for IL-1 pathway antagonists

Given IL1RAP's abnormal expression in various diseases including cancer and autoimmune disorders, it has emerged as a promising target for therapeutic intervention .

Functional Assays

Several assays can be employed to assess the functional activity of recombinant IL1RAP:

  1. Binding Assays: ELISA-based binding assays measuring interaction with IL-1R1 and IL-1β

  2. Cell-Based Assays: Reporter cell lines expressing NF-κB response elements

  3. Co-Immunoprecipitation: Verification of complex formation with IL-1R1

  4. Surface Plasmon Resonance: Quantitative measurement of binding kinetics

Quality Control Parameters

Quality control for recombinant IL1RAP typically includes:

  • Purity assessment by SDS-PAGE (>90% purity standard)

  • Endotoxin testing using the LAL method (<1.0 EU per μg protein)

  • Functional validation through binding assays

  • Mass spectrometry verification of protein identity

  • SEC-HPLC analysis for aggregation assessment

Evolutionary Conservation

IL1RAP demonstrates significant evolutionary conservation across primate species, reflecting the fundamental importance of IL-1 signaling in mammalian immune systems. The high degree of homology between rhesus macaque and human IL1RAP makes the recombinant protein particularly valuable for translational research.

Cross-Reactivity Studies

Studies of recombinant IL1RAP from different species are important for understanding cross-reactivity of therapeutic agents. Research indicates that recombinant human IL-1α demonstrates potent behavioral effects in rhesus monkeys, suggesting a high degree of cross-species activity in the IL-1 signaling pathway . This cross-reactivity extends to the IL1RAP component of the signaling complex.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we understand your specific needs. If you require a particular format, please specify it in your order notes, and we will fulfill your request accordingly.
Lead Time
Delivery time may vary depending on the purchasing method and location. For precise delivery estimates, please consult your local distributor.
Note: All of our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please contact us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal stability, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we suggest adding 5-50% glycerol (final concentration) and aliquotting the solution. Store aliquots at -20°C or -80°C. Our standard glycerol concentration is 50%, which can serve as a reference point for your preparations.
Shelf Life
The shelf life is influenced by various factors, including storage conditions, buffer composition, temperature, and the intrinsic stability of the protein.
Generally, the shelf life for liquid form is 6 months at -20°C/-80°C, while lyophilized form can be stored for 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles to maintain optimal product integrity.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is established during production. If you have a preference for a particular tag, please inform us, and we will prioritize its implementation in the manufacturing process.
Synonyms
IL1RAP; Interleukin-1 receptor accessory protein; IL-1 receptor accessory protein; IL-1RAcP
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
21-570
Protein Length
full length protein
Species
Macaca mulatta (Rhesus macaque)
Target Names
Target Protein Sequence
SERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKFNYSTAHSAGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSPMKLPVHKLYIEYGIQRITCPNVDGYFPSSVKPTITWYMGCYKIQNFNNVIPEGMNLSFLIAFISNNGNYTCVVTYPENGRTFHLTRTLTVKVVGSPKNAVPPVIHSPNDHVVYEKEPGEELLIPCTVYFSFLMDSRNEVWWTIDGKKPDDIPIDVTINESISHSRTEDETRTQILSIKKVTSEDLKRSYVCHARSAKGEVAKAATVKQKVPAPRYTVELACGFGATVLLVVILIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNAEEEEFVLLTLRGVLENEFGYKLCIFDRDSLPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASQGNINVILVQYKAVKETKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRRSSSDEQGLSYSSLKNV
Uniprot No.

Target Background

Function
IL1RAP acts as a coreceptor in the IL-36 signaling system, interacting with IL1RL2. It also serves as a coreceptor with IL1R1 in the IL-1 signaling system. IL1RAP associates with IL1R1 bound to IL1B to form the high-affinity interleukin-1 receptor complex, mediating interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 through their respective TIR domains on the receptor/coreceptor subunits. IL1RAP recruits TOLLIP to the signaling complex. Notably, IL1RAP does not bind to interleukin-1 alone. However, the binding of IL1RN to IL1R1 prevents IL1RAP association with IL1R1, inhibiting the formation of a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. IL1RAP also acts as a coreceptor for IL1RL1 in the IL-33 signaling system. It can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD, potentially playing a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells. Furthermore, IL1RAP associates with secreted ligand-bound IL1R2, enhancing its affinity for IL1B. This complex formation may be the dominant mechanism for neutralizing IL1B through secreted/soluble receptors. IL1RAP enhances the ability of secreted IL1R1 to inhibit IL-33 signaling.
Database Links
Protein Families
Interleukin-1 receptor family
Subcellular Location
[Isoform 1]: Cell membrane; Single-pass type I membrane protein.; [Isoform 2]: Secreted.

Q&A

Basic Research Questions

What is the functional role of IL1RAP in rhesus macaque immune system studies?

IL1RAP (Interleukin-1 Receptor Accessory Protein) serves as a critical co-receptor for IL-1α, IL-1β, and IL-33 signaling, enabling the formation of active receptor complexes that mediate pro-inflammatory responses. In rhesus macaque models, IL1RAP is essential for studying:

  • T follicular helper (Tfh) cell differentiation: IL1RAP modulates cytokine-driven pathways (e.g., IL-6, IP-10) that determine Tfh1 vs. Tfh17 polarization, directly influencing germinal center activity and antibody persistence .

  • Cross-species signaling fidelity: Rhesus IL1RAP shares 94% amino acid homology with humans, making it a robust model for translational immunology studies .

Methodological Recommendation:
To assess IL1RAP's role in immune pathways:

  • Use cytokine-polarized T cell cultures with recombinant IL1RAP-blocking antibodies.

  • Quantify IL1RAP-dependent signaling via phospho-NF-κB/STAT3 flow cytometry.

  • Validate using lymph node biopsies in vaccine challenge models .

What are the standard protocols for recombinant IL1RAP expression in macaque studies?

Recombinant IL1RAP production for macaque research typically involves:

  • Expression system: E. coli (for non-glycosylated proteins) or mammalian cells (for post-translational modifications).

  • Tagging: N-terminal 6xHis-SUMO tags improve solubility and purification yields .

  • Quality control: SDS-PAGE (>90% purity) and endotoxin testing (<1 EU/μg) .

Table 1: Expression Parameters for Recombinant IL1RAP

ParameterSpecification
HostE. coli (BL21) or HEK293 cells
VectorpET-28a(+) or pcDNA3.1
Tag6xHis-SUMO (N-terminal)
Theoretical MW34.1 kDa (unmodified)
Storage-20°C in Tris/PBS + 5–50% glycerol

How is IL1RAP detected and quantified in macaque tissue samples?

  • IHC/IF: Use rabbit polyclonal anti-IL1RAP (NBP2-16946) with pan-cytokeratin counterstaining to localize IL1RAP in epithelial vs. immune cells .

  • ELISA: Commercial kits (e.g., Biomatik RPC21509) detect IL1RAP at sensitivities of 0.1–50 ng/mL .

  • Flow cytometry: Phycoerythrin-conjugated anti-IL1RAP antibodies (clone 3C10) for cell-surface staining.

Critical Note: Cross-reactivity with human IL1RAP antibodies is >95% but requires validation via Western blot using recombinant macaque IL1RAP standards .

Advanced Research Questions

How do IL1RAP-targeting strategies differ between vaccine development and cancer immunotherapy?

Vaccine Context:

  • Adjuvant pairing: IL1RAP inhibition with MPLA+QS-21 enhances Tfh1 polarization, increasing Env antibody persistence by 2.5-fold compared to CAF01-adjuvanted vaccines .

  • Cytokine engineering: DNA primes encoding IP-10/IL-6 synergize with IL1RAP blockade to prolong germinal center reactions (30-week antibody retention vs. 8-week in controls) .

Cancer Context:

  • Antibody-dependent cytotoxicity: Defucosylated anti-IL1RAP mAbs (e.g., CAN04) enhance ADCC by 40% in PDAC xenografts .

  • Chemotherapy synergy: CAN04 + platinum agents reduce IL-6/CRP levels by 60%, overcoming IL1-driven chemoresistance .

Table 2: Comparative Outcomes of IL1RAP Modulation

ApplicationStrategyKey OutcomeSource
HIV VaccinationMPLA+QS-21 + IP-10 DNA prime5,500 ng/mL gp140 IgG at 30 weeks
Pancreatic CancerCAN04 (10 mg/kg) + Cisplatin43% stable disease; CRP ↓ 72%

How do researchers resolve contradictions in IL1RAP signaling data across studies?

Common conflicts arise from:

  • Ligand bias: IL-1α vs. IL-1β activate distinct IL1RAP conformational states, altering downstream NF-κB/AP-1 ratios.

  • Model divergence: Murine IL1RAP lacks the IL-33 binding domain present in primates, limiting translational relevance .

Resolution Protocol:

  • Pathway-specific reporters: Use luciferase-NF-κB/STAT3 constructs in HEK-IL1R1/IL1RAP cells.

  • Ligand titration: Test IL-1α (EC50 = 0.57 μg/mL) vs. IL-1β (EC50 = 0.60 μg/mL) in blockade assays .

  • Single-cell RNA-seq: Profile IL1RAP+ Tfh subsets in macaque lymph nodes post-vaccination .

What methodologies optimize IL1RAP-dependent Tfh profiling in vaccine studies?

  • LN biopsy timing: Sample at 3 weeks post-boost for peak GC Tfh activity (CD4+CXCR5+PD-1+) .

  • Multiparametric cytometry: Panel: CD3/CD4/CXCR5/BCL-6/IL-21/IFN-γ/IL-17A.

  • Tiered neutralization assays: Measure ID50 against HIV-1 pseudoviruses to correlate Tfh1 frequency with antibody potency .

Data Interpretation Tip: Tfh1 dominance (IFN-γ+ >60%) predicts 4-fold higher neutralization breadth compared to Tfh17-skewed responses .

How is IL1RAP biomarker validation performed in preclinical-to-clinical translation?

  • Step 1: Screen FFPE archives using IL1RAP IHC (H-score ≥200 correlates with CAN04 response) .

  • Step 2: Validate soluble IL1RAP (sIL1RAP) via Meso Scale Discovery electrochemiluminescence.

  • Step 3: Correlate sIL1RAP with IL-6 (r = 0.82, p < 0.01) and CRP (r = 0.79, p < 0.01) in serial serum samples .

Table 3: Biomarker Dynamics in CAN04 Trial

BiomarkerBaseline (Mean)Post-Treatment (Δ)p-value
IL-618.2 pg/mL-62%0.003
CRP12.4 mg/L-71%0.001
sIL1RAP4.3 ng/mL+220%0.02

What are the limitations of current IL1RAP targeting approaches?

  • Compensatory signaling: IL-33 upregulation occurs in 30% of CAN04-treated tumors, requiring dual IL1RAP/ST2 blockade .

  • Tfh plasticity: Vaccine-induced Tfh1 cells transiently express IL1RAP (48–72 hr window), necessitating timed booster schedules .

  • Species-specific ADCC: CAN04’s defucosylated Fc has 90% ADCC in human PBMCs but only 35% activity in macaques .

Methodological Innovations

  • IL1RAP crystallography: Murine-human chimeric receptors resolve macaque-specific epitopes for antibody engineering.

  • In vivo CRISPR: Macaque IL1RAP KO models validate on-target/off-immune effects of therapeutic mAbs.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.